Skip to content
Review

Noninvasive Characterization of Tumor Heterogeneity in Locally Advanced Nasopharyngeal Carcinoma: From Progression-Free Survival Prediction to Biological Correlates.

Aug 2026 · Journal of Magnetic Resonance Imaging · 0 citations · 46 references
Medicine

TL;DR

MRI-derived 3D ITH contributed to retrospective PFS risk stratification and showed exploratory cytokine-related transcriptomic correlates that require independent validation that require independent validation.

Abstract

Background

Locally advanced nasopharyngeal carcinoma (LA-NPC) shows substantial variability in progression-free survival (PFS) despite radiotherapy-based treatment. Clinical factors and conventional radiomics may not adequately characterize the spatial organization of intratumoral heterogeneity. Whether topology-aware MRI measures are associated with PFS and transcriptomic features remains unclear.

Purpose

To evaluate an MRI-derived intratumoral heterogeneity (ITH) framework for PFS risk stratification and explore its transcriptomic correlates in LA-NPC. STUDY TYPE Retrospective prognostic modeling study with internal and independent external validation and a separate prospective RNA-sequencing cohort. POPULATION The retrospective cohort included 1001 patients (747 men and 254 women): training, n = 562; internal validation, n = 241; and external validation, n = 198. The prospective RNA-sequencing cohort included 53 patients (38 men and 15 women). FIELD STRENGTH/SEQUENCE Pretreatment 3.0-T axial contrast-enhanced T1-weighted fast/turbo spin-echo MRI. ASSESSMENT Primary tumors were manually segmented and reviewed by two senior radiologists. 2D and 3D ITH scores and conventional radiomics features were evaluated using survival models. Transcriptomic correlates were assessed using differential expression, co-expression network, and gene set enrichment analyses. STATISTICAL TESTS Model discrimination was assessed using the concordance index (C-index) with 95% confidence intervals. Shapley additive explanations (SHAP) were used for model interpretation. Transcriptomic analyses used Benjamini-Hochberg false discovery rate (FDR) correction.

Results

The integrated heterogeneity-clinical DeepSurv model yielded C-indices of 0.727 (95% CI, 0.674-0.782) in the internal validation cohort and 0.714 (95% CI, 0.661-0.770) in the external validation cohort. The 3D ITH score had the largest mean absolute SHAP value (0.0554) among the model predictors. High 3D ITH scores were associated with enrichment of cytokine-cytokine receptor interaction (normalized enrichment score [NES] = 1.57; FDR = 0.00705) and viral protein interaction with cytokine and cytokine receptor signaling (NES = 1.77; FDR = 0.00264). DATA

Conclusion

MRI-derived 3D ITH contributed to retrospective PFS risk stratification and showed exploratory cytokine-related transcriptomic correlates that require independent validation. EVIDENCE LEVEL 3. TECHNICAL EFFICACY Stage 2.

View source

Similar papers

Open access Sep 2026

MRI-derived features reveal recurrence heterogeneity in VI-RADS 2 non-muscle-invasive bladder cancer

Objectives To characterize recurrence heterogeneity among patients with VI-RADS 2 non-muscle-invasive bladder cancer (NMIBC) and to develop and internally validate a recurrence-free survival (RFS) prediction model incorporating quantitative MRI features. Methods This retrospective study included 342 patients with patho...

Jun-Peng Sun, Ziyong Wang, Maoa Yang et al. · 0 citations
Open access Sep 2026

Multimodal Large Language Models for Prognostic Prediction in Cervical Cancer Treated with Definitive Chemoradiotherapy: An Exploratory Study of Systematic Multimodal Data Integration

Assessment of whether a general-purpose Multimodal large language model could both generate a structured report from pelvic MRI images and combine clinical, laboratory, treatment and imaging data to estimate recurrence risk found it was often discordant in specific and clinically important ways.

Zhao-Qi Gu, Chen Wang, Qi-Zhen Zhu et al. · 0 citations
Open access Aug 2026

Risk stratification and boost dose optimization for locoregionally advanced nasopharyngeal carcinoma with residual lesions based on clinical stage and post-radiotherapy EBV DNA

Background Residual locoregionally advanced nasopharyngeal carcinoma (LA-NPC) after definitive chemoradiation leads to poor outcomes, but current treatments lack standardized, evidence-based guidance for individualized dose escalation, causing varied practices. Objective To develop a risk-stratification model to person...

Xinyi Hong, Yi Li, Chao-Ying Lin et al. · 0 citations
Open access Sep 2026

Two-year dynamic risk stratification and adjuvant radioiodine efficacy in initial non-distant metastatic papillary thyroid carcinoma harboring TERT promoter mutations

Background The clinical utility of postoperative radioiodine (131I) ablation remains unclear for patients with initially diagnosed non-distant metastatic papillary thyroid carcinoma (PTC) with harboring TERT promoter(TERT-p) mutations, it is unknown whether 131I therapy reduces the risk of persistent or recurrent disea...

Xian-Zhao Deng, Meng-Yue Liu, Chen-Tian Shen et al. · 0 citations
Sep 2026

Preoperative CT-based radiomics prediction of tertiary lymphoid structures and prognostic integration with pathological microvascular invasion in resectable hepatocellular carcinoma: a multicenter study.

OBJECTIVES Tertiary lymphoid structures (TLS) reflect the tumor immune microenvironment and may provide prognostic information in hepatocellular carcinoma (HCC), but assessment requires pathology. This study aimed to develop and externally validate a CT radiomics-based machine-learning model for preoperative prediction...

Yong-Ming Tan, Si-Ya Xu, Meng Liu et al. · 0 citations
Open access Sep 2026

Pretreatment EBV-DNA/TLG-Based Risk Stratification Is Associated With Survival Outcomes in Nonmetastatic Nasopharyngeal Carcinoma: An Exploratory Study.

Whether combining pretreatment plasma Epstein-Barr virus DNA (EBV-DNA) with 18F-FDG PET/CT-derived total lesion glycolysis (TLG) improves prognostic stratification in nonmetastatic nasopharyngeal carcinoma (NPC) is unclear, particularly in nonendemic populations. We retrospectively analyzed 86 eligible nonmetastatic NP...

M. Duymaz, Ece Özkaya Duymaz, Nazlı Ünsal et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.